Home » Topics » BioWorld Science

BioWorld Science
RSS

Biomira withdraws NDS for Tru-Scint imaging kit

Dec. 1, 1997

U.S. patent covers new melanoma antigen/MAb discovered by Cytoclonal

Dec. 1, 1997

Phase I/II clinical trial of gene therapy for melanoma

Dec. 1, 1997

FDA approves Gensia Laboratories' generic bumetanide injection

Dec. 1, 1997

IL-2 gene therapy for metastatic solid tumors: phase I results

Dec. 1, 1997

New anesthetic agent in phase I at Synthelabo

Dec. 1, 1997

Gynecare merges with Johnson & Johnson

Dec. 1, 1997

Effects of AE-0047 on cerebral ischemia/edema and renal injury

Dec. 1, 1997

AVID study results reported

Dec. 1, 1997

Dual-action compound YM-158 shows potential for asthma

Dec. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026